ArticleCommunications biology2025

LRRK2-mutant microglia and neuromelanin synergize to drive dopaminergic neurodegeneration in an iPSC-based Parkinson's disease model.

Lucas Blasco-Agell et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.